Advertisement

Topics

Collaboration Aims to Expedite Diagnostic Testing in Emergencies.

08:00 EDT 2nd April 2019 | BioPortfolio

Summary of "Collaboration Aims to Expedite Diagnostic Testing in Emergencies."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: JAMA
ISSN: 1538-3598
Pages: 1245

Links

DeepDyve research library

PubMed Articles [11181 Associated PubMed Articles listed on BioPortfolio]

Macrodetermined racial inequalities in diagnostic testing among tuberculosis patients in Brazil.

To estimate the association between tuberculosis (TB) patients' race and patients' access to diagnostic testing in Brazil. In addition, we evaluated if the associations could be explained by a geograp...

Trends in Hospitalization, Readmission, and Diagnostic Testing of Patients Presenting to the Emergency Department With Syncope.

Emergency department (ED) visits for syncope are common and routine diagnostic testing is frequently low yield. Our objective is to determine whether recent guidelines emphasizing limiting hospitaliza...

Spinal Emergencies in Primary Care Practice.

Atraumatic spinal emergencies often present a diagnostic and management dilemma for healthcare practitioners. Spinal epidural abscess, cauda equina syndrome, and spinal epidural hematoma are condition...

The HIV diagnostic assistant-early findings from a novel HIV testing cadre in Malawi.

In 2015, Malawi piloted the HIV Diagnostic Assistant (HDA), a cadre of lay health worker focused primarily on HIV testing services. Our objective is to measure the effect of HDA deployment on country-...

The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access.

Little is known about the utilization of cardiac diagnostic testing in Brazil and how such testing is related with local rates of acute coronary syndrome (ACS)-related mortality.

Clinical Trials [6360 Associated Clinical Trials listed on BioPortfolio]

Piloting At-birth Point of Care HIV Testing Strategies in Kenya

Innovative strategies to expedite HIV diagnosis among exposed infants, including at-birth testing and two portable point-of-care (POC) diagnostic systems, will be evaluated from an impleme...

Global CMR Registry

The Global CMR Registry aims to promote collaboration of CMR sites worldwide in setting imaging and reporting standards, assessing its diagnostic impact on patient care, and determining th...

BECOME PATIENTS IN THE EMERGENCIES OF UHC POITIERS

The number of consultations in the emergency services has continued to increase with 19.7 million passages in 2014, an increase of 4% compared to 2013. Among these admissions, many patient...

Safety of a Diagnostic Strategy With D-Dimer Testing for PE

To determine whether D-Dimer testing, using the MDA D-Dimer assay, can be used to simplify the diagnostic process for pulmonary embolism (PE). This will be assessed by performing a cohort...

What Care Pathways for Newborns Consulting Pediatric Emergencies? Prospective Study Over One Year

This study will evaluate the course of care of newborns, to understand why some newborns have improper care pathways, particularly as regards the first medical consultation at the exit of ...

Medical and Biotech [MESH] Definitions

Laboratory testing and diagnostic imaging services offered to consumers outside of the patient-physician relationship.

Assessments aimed at determining agreement in diagnostic test results among laboratories. Identical survey samples are distributed to participating laboratories, with results stratified according to testing methodologies.

Allows patient diagnoses in the physician’s office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)

The process of gaining approval by a government regulatory agency for DIAGNOSTIC REAGENTS AND TEST KITS. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance.

Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...


Searches Linking to this Article